Doozio Posted - 22 hours ago

$IGMS no faatch 💣 n it’s 🧠⏰♾️

JBResearch Posted - 1 day ago

$IGMS No external analysis of that updated Sanofi agreement on april 17 yet?

StockScanners Posted - 04/30/24

$IGMS this weeks high at 10.47, looking for more

StockScanners Posted - 04/29/24

$IGMS reached 10.47, need bases support at 10 for bigger move, for now need support above 9

JBResearch Posted - 04/29/24

$IGMS Still has it's future kinda tied to Sanofi, because of that (recently downsized) collaboration agreement ... $SNY https://markets.businessinsider.com/news/stocks/buy-rating-affirmed-for-sanofi-amid-strong-growth-prospects-and-undervalued-stock-1033275869

Fullratio Posted - 04/28/24

$IGMS gross profit has surged by 99% YoY and by 15% QoQ: https://fullratio.com/stocks/nasdaq-igms/igm-biosciences

StockScanners Posted - 04/27/24

$IGMS Keep watch if this holds above 8.50, watch for break at 9.75, new support needs to hold above 9.50, looking for 12

Doozio Posted - 04/27/24

$IGMS a Thursday 🐑 low as a 🧠👀 becomes 🧠⏰ FRYday? Now all yo gotta do is wUtch da huckleberries n 🙏 no faatch 💣

S_Franconi Posted - 04/26/24

$IGMS Great day here!

_StockTrader Posted - 04/26/24

Real-Time Stock Data $IGMS Price: 9.61 Volume: 252769 Market Cap: 528491520 PE Ratio: -3.1215277 Powered by: PSYC

Secret_Stocks Posted - 04/25/24

$IGMS the company better banning the deal with sanofi otherwise we are going to a penny stock. We are from $2b mk cap to now $497m. A significantly dropped. Ceo, we needs to know

Secret_Stocks Posted - 04/25/24

$IGMS no news and we dropped 19% under low low volume. WTF people?

Secret_Stocks Posted - 04/25/24

$IGMS ceo should get fire and hang. Unless? Get your fat ass OOOand do something 😩😩😩

Secret_Stocks Posted - 04/23/24

$IGMS who in Charge of this co.? Htf you let your company dropped from $23 to $6s? Unacceptable!

2PacalypseNow4Life Posted - 04/22/24

$IGMS https://finance.yahoo.com/news/igm-biosciences-insiders-placed-bullish-114503853.html

DonCorleone77 Posted - 04/18/24

$IGMS $SNY IGM Biosciences weakness creates 'interesting opportunity,' says Stifel After IGM Biosciences (IGMS) announced that the company's exclusive worldwide collaboration agreement with Sanofi (SNY) to create and develop IgM agonist antibodies will now focus exclusively on immunology and inflammation targets, Stifel analyst Stephen Willey said the firm believes the re-focusing of the collaboration away from oncology and exclusively to the three, yet-to-be-disclosed IAI targets "removes some longer-term economic optionality," but ultimately doesn't change the firm's thesis on the stock. The firm, which adds that Sanofi's decision aligns with its continued prioritization of IAI development opportunities and doesn't reflect anything aplitabart-related and notes that IGM now regains full control of these oncology programs and could potentially re-monetize these assets via future partnerships, would be buyers on related weakness. Stifel has a Buy rating and $25 price target on IGM Biosciences shares.

briefingcom Posted - 04/17/24

$IGMS: IGM Biosciences announced its exclusive worldwide collaboration agreement with Sanofi (SNY) to create and develop IgM agonist antibodies will now focus exclusively on immunology/inflammation targets https://www.briefing.com/in-depth-analysis/content/article?ArticleId=IN20240417083328IGMS&utm_campaign=inplay&utm_medium=social&utm_source=st&utm_content=view_page

DonCorleone77 Posted - 04/17/24

$IGMS $SNY IGM Biosciences announces refocusing of Sanofi collaboration IGM Biosciences (IGMS) announced that the Company's exclusive worldwide collaboration agreement with Sanofi (SNY) to create and develop IgM agonist antibodies will now focus exclusively on immunology/inflammation targets. IGM will retain global rights to its proprietary technology related to the oncology targets nominated by Sanofi under the collaboration. As previously announced, under the terms of the collaboration agreement, for each of the three Sanofi designated immunology/inflammation targets, IGM will lead research and development activities and assume related costs through the completion of a Phase 1 clinical trial for up to two constructs directed to each target, after which Sanofi will be responsible for all future development and commercialization activities and associated costs. IGM will be eligible to receive up to $1,065 million in aggregate development, regulatory and commercial milestones per target as well as tiered high single-digit to low-teen royalties on global net sales.

Stock_Titan Posted - 04/17/24

$IGMS IGM Biosciences Announces Refocusing of Sanofi Collaboration https://www.stocktitan.net/news/IGMS/igm-biosciences-announces-refocusing-of-sanofi-e4577jcbzgli.html

Capes Posted - 04/14/24

$TPET $MNDR $GL $QTI $IGMS

NOTaPUNDIT Posted - 04/12/24

GREEN on a red day $XTIA $BROG $IGMS $HKD $JL

rangerhawkeye Posted - 04/10/24

$IGMS added here for a swing

Stock_Titan Posted - 04/10/24

$IGMS IGM Biosciences to Present at the Stifel 2024 Virtual Targeted Oncology Forum https://www.stocktitan.net/news/IGMS/igm-biosciences-to-present-at-the-stifel-2024-virtual-targeted-857gn13sj42z.html

EquityInvest Posted - 04/08/24

$IGMS get ready for $4!!!!

rangerhawkeye Posted - 04/07/24

$PRME $IGMS oversold plays for this week, baker bros bought the latter recently

Qmoney1992 Posted - 4 weeks ago

$IGMS I like this one 😎

Bugseason Posted - 1 month ago

$IGMS in for the ride

optiresearch Posted - 1 month ago

$IGMS Volatile stock. PRICE TARGET $14.02

RamenLives Posted - 03/29/24

$IGMS @G101SPM Hello, could you please run this one? Thanks

insiderbuyingselling Posted - 03/28/24

$IGMS new insider buying: 395317 shares. http://insiderbuyingselling.com/?t=IGMS